Cara Therapeutics' market value is the price at which a share of Cara Therapeutics trades on a public exchange. It measures the collective expectations of Cara Therapeutics investors about its performance. Cara Therapeutics is trading at 4.84 as of the 8th of January 2025. This is a No Change since the beginning of the trading day. The stock's lowest day price was 4.84. With this module, you can estimate the performance of a buy and hold strategy of Cara Therapeutics and determine expected loss or profit from investing in Cara Therapeutics over a given investment horizon. Check out Cara Therapeutics Correlation, Cara Therapeutics Volatility and Cara Therapeutics Alpha and Beta module to complement your research on Cara Therapeutics.
Please note, there is a significant difference between Cara Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Cara Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Cara Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Cara Therapeutics 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Cara Therapeutics' stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Cara Therapeutics.
0.00
01/19/2023
No Change 0.00
0.0
In 1 year 11 months and 22 days
01/08/2025
0.00
If you would invest 0.00 in Cara Therapeutics on January 19, 2023 and sell it all today you would earn a total of 0.00 from holding Cara Therapeutics or generate 0.0% return on investment in Cara Therapeutics over 720 days. Cara Therapeutics is related to or competes with Superior Plus, NMI Holdings, SIVERS SEMICONDUCTORS, Talanx AG, NorAm Drilling, Identiv, and Norsk Hydro. Cara Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing and commercializing chemical ... More
Cara Therapeutics Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Cara Therapeutics' stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Cara Therapeutics upside and downside potential and time the market with a certain degree of confidence.
Today, many novice investors tend to focus exclusively on investment returns with little concern for Cara Therapeutics' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Cara Therapeutics' standard deviation. In reality, there are many statistical measures that can use Cara Therapeutics historical prices to predict the future Cara Therapeutics' volatility.
Cara Therapeutics is dangerous given 3 months investment horizon. Cara Therapeutics secures Sharpe Ratio (or Efficiency) of 0.17, which signifies that the company had a 0.17% return per unit of risk over the last 3 months. We were able to interpolate twenty-four different technical indicators, which can help you to evaluate if expected returns of 1.84% are justified by taking the suggested risk. Use Cara Therapeutics Risk Adjusted Performance of 0.1115, downside deviation of 7.02, and Mean Deviation of 6.99 to evaluate company specific risk that cannot be diversified away. Cara Therapeutics holds a performance score of 13 on a scale of zero to a hundred. The firm shows a Beta (market volatility) of -0.77, which signifies possible diversification benefits within a given portfolio. As returns on the market increase, returns on owning Cara Therapeutics are expected to decrease at a much lower rate. During the bear market, Cara Therapeutics is likely to outperform the market. Use Cara Therapeutics total risk alpha, treynor ratio, and the relationship between the jensen alpha and sortino ratio , to analyze future returns on Cara Therapeutics.
Auto-correlation
0.52
Modest predictability
Cara Therapeutics has modest predictability. Overlapping area represents the amount of predictability between Cara Therapeutics time series from 19th of January 2023 to 14th of January 2024 and 14th of January 2024 to 8th of January 2025. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Cara Therapeutics price movement. The serial correlation of 0.52 indicates that about 52.0% of current Cara Therapeutics price fluctuation can be explain by its past prices.
Correlation Coefficient
0.52
Spearman Rank Test
0.72
Residual Average
0.0
Price Variance
6.37
Cara Therapeutics lagged returns against current returns
Autocorrelation, which is Cara Therapeutics stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Cara Therapeutics' stock expected returns. We can calculate the autocorrelation of Cara Therapeutics returns to help us make a trade decision. For example, suppose you find that Cara Therapeutics has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values
Timeline
Cara Therapeutics regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Cara Therapeutics stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Cara Therapeutics stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Cara Therapeutics stock over time.
Current vs Lagged Prices
Timeline
Cara Therapeutics Lagged Returns
When evaluating Cara Therapeutics' market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Cara Therapeutics stock have on its future price. Cara Therapeutics autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Cara Therapeutics autocorrelation shows the relationship between Cara Therapeutics stock current value and its past values and can show if there is a momentum factor associated with investing in Cara Therapeutics.
Cara Therapeutics financial ratios help investors to determine whether Cara Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Cara with respect to the benefits of owning Cara Therapeutics security.